All Stories

  1. Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer
  2. A Phospholipase-A Activity in Soluble Leishmania Antigens Causes Instability of Liposomes
  3. The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib
  4. The Effect of Nanocurcumin in Improvement of Knee Osteoarthritis: A Randomized Clinical Trial
  5. In silico and In vitro investigation of a likely pathway for anti-cancerous effect of Thrombocidin-1 as a novel anticancer peptide
  6. P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer
  7. Enhancement of the effect of BCG vaccine against tuberculosis using DDA/TDB liposomes containing a fusion protein of HspX, PPE44, and EsxV
  8. Regulation of in vivo behavior of TAT-modified liposome by associated protein corona and avidity to tumor cells
  9. Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo
  10. The role of LPD-nanoparticles containing recombinant major surface glycoprotein of Leishmania (rgp63) in protection against leishmaniasis in murine model
  11. Stimulation of Tumor-Specific Immunity by p5 HER-2/neu Generated Peptide Encapsulated in Nano-liposomes with High Phase Transition Temperature Phospholipids
  12. Biodistribution and In Vivo Antileishmanial Activity of 1,2-Distigmasterylhemisuccinoyl-sn-Glycero-3-Phosphocholine Liposome-Intercalated Amphotericin B
  13. PNC27 anticancer peptide as targeting ligand significantly improved antitumor efficacy of Doxil in HDM2-expressing cells
  14. Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers
  15. Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends